• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

血小板活化因子受体。2. 激动剂醚氧化链的定量疏水贡献。

PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.

作者信息

Heymans F, Steiner E, Jouquey S, Godfroid J J

机构信息

Laboratoire de Pharmacochimie Moléculaire, Université Paris, France.

出版信息

J Lipid Mediat. 1989 Sep-Oct;1(5):303-12.

PMID:2562436
Abstract

In order to undertake a quantitative assessment of the contribution of the hydrophobic effect of the etheroxid chain to agonistic activity, it was necessary to include in the calculated data a highly lipophilic platelet-activating factor (PAF) analogue. The synthesis of such a compound--racemic 1-O-docosyl-2-O-acetylglycero-3-phosphocholine (C22 PAF)--is described. The regression analysis performed with data of 14 etheroxid analogues (reviewed by Godfroid et al., 1987), combined with data obtained with C22 PAF, is significant with respect to a parabolic evolution between lipophilicity of the chain and the logarithm of relative platelet stimulation. This result is characteristic of a hydrophobic interaction between the agonist and the PAF receptor.

摘要

为了对醚氧化链的疏水作用对激动活性的贡献进行定量评估,有必要在计算数据中纳入一种高度亲脂性的血小板激活因子(PAF)类似物。本文描述了此类化合物——外消旋1-O-二十二烷基-2-O-乙酰甘油-3-磷酸胆碱(C22 PAF)的合成。对14种醚氧化类似物的数据(Godfroid等人于1987年综述)以及C22 PAF获得的数据进行回归分析,结果表明链的亲脂性与相对血小板刺激对数之间呈抛物线演变,具有显著性。该结果是激动剂与PAF受体之间疏水相互作用的特征。

相似文献

1
PAF receptor. 2. Quantitative hydrophobic contribution of the agonist's etheroxid chain.血小板活化因子受体。2. 激动剂醚氧化链的定量疏水贡献。
J Lipid Mediat. 1989 Sep-Oct;1(5):303-12.
2
Structure-activity relationships for platelet-activating factor (PAF) and analogues reveal differences between PAF receptors on platelets and macrophages.血小板活化因子(PAF)及其类似物的构效关系揭示了血小板和巨噬细胞上PAF受体之间的差异。
J Lipid Mediat. 1991 Nov;4(3):299-308.
3
PAF-agonistic and -antagonistic behaviour of new synthetic ether phospholipids. I. Studies on blood platelets in vitro.
J Lipid Mediat. 1990 Jan-Feb;2(1):21-31.
4
Agonistic activity and charge driven interaction potentiality of PAF derivatives.血小板激活因子(PAF)衍生物的激动活性和电荷驱动相互作用潜力。
Farmaco. 1993 Oct;48(10):1379-99.
5
[Effect of analogs and antagonists of the thrombocyte-activating factor (PAF) on blood platelet aggregation].
Farmakol Toksikol. 1988 Jul-Aug;51(4):113-23.
6
Biological effects of the new platelet-activating factor receptor antagonist (+)-cis-3,5-dimethyl-2-(3-pyridyl)thiazolidin-4-one hydrochloride.新型血小板活化因子受体拮抗剂(+)-顺式-3,5-二甲基-2-(3-吡啶基)噻唑烷-4-酮盐酸盐的生物学效应
Arzneimittelforschung. 1994 Mar;44(3):317-22.
7
Biochemical and pharmacological characterization of L-659,989: an extremely potent, selective and competitive receptor antagonist of platelet-activating factor.L-659,989的生化与药理学特性:一种血小板活化因子的超强效、选择性及竞争性受体拮抗剂
J Pharmacol Exp Ther. 1988 Aug;246(2):534-41.
8
Platelet-activating factor (PAF) mediation of rat anaphylactic responses to soluble immune complexes. Studies with PAF receptor antagonist L-652,731.血小板活化因子(PAF)介导大鼠对可溶性免疫复合物的过敏反应。PAF受体拮抗剂L-652,731的研究。
J Immunol. 1986 Jun 15;136(12):4659-68.
9
Pharmacological characterization of a receptor for platelet-activating factor on guinea pig peritoneal macrophages using [3H]apafant, a selective and competitive platelet-activating factor antagonist: evidence that the noncompetitive behavior of apafant in functional studies relates to slow kinetics of dissociation.使用[3H]阿帕泛(一种选择性竞争性血小板活化因子拮抗剂)对豚鼠腹腔巨噬细胞上血小板活化因子受体进行药理学特性研究:阿帕泛在功能研究中的非竞争性行为与解离动力学缓慢有关的证据。
Mol Pharmacol. 1993 Feb;43(2):302-12.
10
High affinity specific binding sites for tritiated platelet-activating factor in canine platelet membranes: counterparts of platelet-activating factor receptors mediating platelet aggregation.犬血小板膜中氚标记血小板活化因子的高亲和力特异性结合位点:介导血小板聚集的血小板活化因子受体对应物。
Mol Pharmacol. 1988 Aug;34(2):145-51.

引用本文的文献

1
Platelet-activating factor antagonists.血小板活化因子拮抗剂
Clin Rev Allergy. 1994 Winter;12(4):361-80. doi: 10.1007/BF02802300.
2
PAF. A review of its effects, antagonists and possible future clinical implications (Part II).血小板活化因子。其作用、拮抗剂及未来可能的临床意义综述(第二部分)
Drugs. 1991 Aug;42(2):174-204. doi: 10.2165/00003495-199142020-00002.
3
PAF receptor structure: a hypothesis.
Lipids. 1991 Dec;26(12):1162-6. doi: 10.1007/BF02536523.